Human platelet alloantigens

Wiener Klinische Wochenschrift

Volumn 113, Issue 20-21, 2001, Pages 806-813

  Santoso, S ^a   Kiefel, V ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Alloimmune thrombocytopenia; Diagnostics; Human platelet alloantigens; Structure

Indexed keywords

ALLOANTIGEN; BLOOD GROUP B ANTIGEN; HLA ANTIGEN; LEUKOCYTE ANTIGEN; THROMBOCYTE ANTIGEN;

ALLOIMMUNITY; ANTIBODY PRODUCTION; BLOOD GROUP ABO SYSTEM; BLOOD TRANSFUSION REACTION; HUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PURPURA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA;

ANTIGENS, HUMAN PLATELET; BLOOD PLATELETS; DIAGNOSIS, DIFFERENTIAL; GENOTYPE; GLYCOPROTEINS; HUMANS; MUTATION; PHENOTYPE; POLYMORPHISM, GENETIC; RISK FACTORS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0035976055     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. 348 Cases of suspected neonatal alloimmune thrombocytopenia
2. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): A new tool for the identification of platelet reactive antibodies
3. Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction
4. Human platelet-specific alloantigens: Update
5. The origin of ABH antigens on human platelets
6. Expression of ABH and X (Lex) antigens on platelets and lymphocytes
7. Blood group A and B determinants are expressed on platelet glycoproteins IIa, IIIa, and Ib
8. PECAM is the major glycoprotein carrying blood group antigens
9. Study on expression of ABH antigens on platelets
10. Evidence for an expression of blood group A antigen on platelet glycoproteins IV and V
11. Blood group A antigen expression in platelets is prominently associated with glycoprotein Ib and IIb. Evidence for an A1/A2 difference
12. ABH antigens on human platelets: Expression on the glycosyl phosphatidylinositol-anchored protein CD109
13. ABH antibodies causing platelet transfusion refractoriness
14. Minimal expression of blood group A antigen on thrombocytes from A2 individuals
15. Blood group A and B antigens are strongly expressed on platelets of some individuals
16. Expression of HLA-B12 on platelets, on lymphocytes and in serum: A quantitative study
17. Role of HLA C matching in histocompatible platelet transfusion therapy of alloimmunized thrombocytopenic patients
18. HLA-C antigens on platelets
19. Ability of thrombocytes to acquire HLA specificity from plasma
20. HLA antigens on platelet membranes. In vitro and in vivo studies
21. The presence of messenger RNA for HLA class I in human platelets and its capability for protein biosynthesis
22. Biochemical characterization of 39-kDa class I histocompatibilty antigen in plasma. A secretable membrane protein derived from transmembrane domain deletion
23. Alternatively spliced mRNA encoding for soluble HLA class I antigens is not detactable in platelets
24. A1) on human vascular smooth muscle cells and foreskin fibroblasts: A study on normal individuals and a patient with Glanzmann's thrombasthenia
25. b are expressed on the very late activation antigen 2 (VLA-2) of T-lymphocytes
26. The platelet glycoprotein Ia-IIa associated with Br-alloantigen system is expressed by cultured endothelial cells
27. Alloantigenic composition of the endothelial vitronectin receptor
28. ICSH/ISBT Working Party on platelet serology nomenclature of platelet-specific antigens
29. A2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing
30. The NH2-terminal globular domain of human platelet glycoprotein Iba has a methionine145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens
31. b alloantigen system
32. b alloantigen system
33. b are associated with a single amino acid polymorphism on glycoprotein Ia (integrin subunit α2)
34. Amino acid 489 is a mutational "hot spot" on the b3 integrin chain. The CA/Tu human platelet alloantigen system
35. Single point mutation in human glycoprotein IIIa is associated with a new platelet-specific alloantigen (Mo) involved in neonatal alloimmune thrombocytopenia
36. a alloantigen system of GPIIIa
37. a, a new low-frequency platelet-specific antigen localized on glycoprotein IIb, is associated with neonatal alloimmune thrombocytopenia
38. a): Genetic determination of a new platelet-specific alloantigen on glycoprotein IIIa and its expression in COS-7 cells
39. a unravelled by SSCP analysis and direct sequencing
40. a
41. a and affects collagen-induced aggregation
42. a
43. a, on glycoprotein IIIa, involved in neonatal alloimmune thrombocytopenia
44. Glycoprotein Ib/IX-specific alloimmunization in an HPA 2b-homozygous mother in association with neonatal thrombocytopenia
45. a/b alloantigen system on human platelets
46. Platelet alloantigen frequencies in Caucasian: A serological study
47. Frequency of platelet-specific antigens among Indonesians
48. Nomenclature of human platelet alloantigens: A problem with the HPA system?
49. Guidelines for human gene nomenclature. An international sytem for human gene nomenclature (ISGN, 1987)
50. A1: Localization to 17,000 Dalton polypeptide
51. A1 epitope
52. A1 epitope to the aminoterminal 66 residues of platelet glycoprotein IIIa
53. A2
54. A1 antigens on human β3 integrin
55. 3 subunit
56. A1. Evidence for heterogeneity in the humoral response
57. A1 antibodies to platelets with monoclonal antibody LK-4. Evidence for multiple PIA 1 receptor sites on platelet glycoprotein IIIa
58. a
59. A and Bak alloantigenic epitopes
60. a (HPA 3a) to the C terminus of platelet glycoprotein IIb heavy chain and contribution of O-linked carbohydrates
61. a (HPA 3a) alloantigen expression
62. Effect of single amino acid substitution and glycosylation of GPIa on the formation of Br alloantigenic epitopes
63. A1 antigen
64. Molecular identification of T cells that respond in primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia
65. A2)
66. An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding. A model for unidirectional alloimmune response
67. Susceptibility to alloimmunization to platelet HPA-1a antigen involves Tap1 polymorphism
68. a
69. Genetic susceptibility and anti-human platelet antigen 5b alloimmunization role of HLA class II and TAP genes
70. Clinical aspects and typing of platelet alloantigens
71. Should all pregnant women be tested for their platelet PIA (Zw, HPA-1) phenotype
72. Development and validation of a genotyping kit for the eight principal human platelet alloantigen systems
73. B-lymphoblastoid cell lines as a source of reference DNA for human platelet and neutrophil antigen genotyping
74. Workshop report on the genotyping of blood cell alloantigens
75. Human platelet alloantigen typing: PCR analysis is not a substitute for serological methods
76. A2 allelic form of glycoprotein IIIa: Implications for their correlation of serologic versus genotypic analysis of human platelet alloantigens
77. Frequency of Glanzmann's thrombasthenia carriers estimated by discrepancies in platelet alloantigen typing strategies
78. The MAIPA assay and its applications in immunohaematology
79. A human monoclonal antibody specific for the leucine-33 (PIA1, HPA-1a) form of platelet glycoprotein IIIa from a V gene phage display library
80. Human monoclonal Fab fragments recovered from a combinatorial library bind specifically to the platelet HPA-1 a alloantigen on glycoprotein IIb-IIIa
81. Maternal anti-HLA antibodies and neonatal thrombocytopenia
82. Graft-derived anti-HPA2b production after allogenic bone-marrow transplantation
83. A1 specificity: Evidence for a host-derived immune reaction
84. Human platelet alloantigen (HPA)-5a/b mismatch decreasese disease-free survival in unrelated bone marrow transplantation
85. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis
86. HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction
87. The role of the glycoprotein IIb fibrinogen receptor subunit T2622G gene polymorphism (HPA-3) on coronary artery disease and acute myocardial infarction
88. The impact of the glycoprotein Ia receptor subunit A1648G gene polymorphism on coronary artery disease and acute myocardial infarction
89. Polymorphism of platelet glycoprotein Iba associated with arterial thrombotic disease